To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

Post Category: Press

February 10, 2023
New Device Detects Brain Tumors Early, From Urine

Membrane proteins in urine can indicate a brain tumor early, according to researchers at Nagoya University in Japan. The could avoid the need for invasive tests and increase the likelihood of tumors being detected early enough for surgery.

Read More
June 24, 2021
ASCO Annual Meeting Wrap Up

As a proud member of ASCO (American Society of Clinical Oncology), I am consistently impressed with the information they provide. They recently held their Annual Event I wanted to take the time to provide some of the incredible information and data that resulted from that meeting.

Read More
August 1, 2019
The EndBrainCancer Initiative Urges Support for New FDA Clinical Trial Diversity Guidelines and Proposes Key Amendments

The EndBrainCancer Initiative (EBCI) urges support for the new guidelines proposed by the FDA entitled “Enhancing the Diversity of Clinical Trial Populations – Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry.”

Read More
April 3, 2019
Patients, Survivors, Friends, and Partners Celebrate The EndBrainCancer Initiative’s GBM Patient & TOGETHER Day

The EndBrainCancer Initiative Initiative recently hosted its first ever GBM Patient & TOGETHER Day on Friday, March 15th at the Bellevue Club in Bellevue, Washington

Read More
March 14, 2019
GBM Patient & TOGETHER Day to Honor and Uplift Brain Cancer Patients on Friday, March 15th

The EndBrainCancer Initiative is hosting its first ever GBM Patient & TOGETHER Day on Friday, March 15th at the Bellevue Club in Bellevue, Washington. Current and past brain cancer patients, survivors, caregivers, and families are invited to this special event

Read More
August 30, 2018
With Condolences to the McCain Family, The End Brain Cancer Initiative Calls for New Access and Treatment Options for Brain Cancer Patients & Changes to Standard of Care

The End Brain Cancer Initiative (EBCI) joins other organizations to honor Senator McCain’s life and fight against brain cancer. EBCI calls for National Concerted Action that Offers New Access and Treatment Availability for Brain Cancer Patients.

Read More
August 8, 2018
The EndBrainCancer Initiative Receives CITI Certification Becoming the First Brain Tumor Patient Advocacy Organization Listed as a Nationally-Recognized Recruiting Site

The EndBrainCancer Initiative received CITI certification to recruit caregivers to participate in brain cancer caregiver and patient clinical trials at the Pacific Neuroscience Institute and John Wayne Cancer Institute in conjunction with Providence Health Services of Southern California.

Read More
February 26, 2017
John Brace: Inspiration, Laughter, and the work of the End Brain Cancer Initiative

John Brace was the first person I ever had the honor of helping with his brain cancer diagnosis other than my late husband Chris.

Read More
January 23, 2016
An Open Letter to Vice President Biden:

Believe me, I have been thinking about you ever since I learned of your son, Beau’s, diagnosis and even more so after his death. I do not know what it is to lose a son but I do know what it is to lose a husband .

Read More
October 22, 2015
ChrisElliottFund Officially Re-launched as The EndBrainCancer Initiative

The reason for the name change is to increase awareness of our patient support programs that fuel cancer research with a patient focus.

Read More
October 22, 2015
EndBrainCancer / Chris Elliott Fund Honored as Social Impact Innovator

SVP Fast Pitch is the region’s premier competition igniting social innovation. We are proud to report that  EndBrainCancer / Chris Elliott Fund made it as a quarterfinalist!

Read More
October 22, 2015
Dellann Elliott Mydland to Speak at 2nd Annual Turning Point Conference, San Antonio,

Dellann Elliott Mydland will be a featured speaker at a national brain tumor conference.

Read More


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram